猪白细胞介素_6在巴斯德毕氏酵母（Pichia pastoris）中的分泌表达

白细胞介素6（Interleukin_6, IL_6）是一种具有多种生物学效应的细胞因子,在疾病诊断与疫苗佐剂领域有广阔的应用前景。在本试验中,猪白细胞介素_6（pIL_6）的cDNA序列被克隆入甲醇酵母（Pichia pastoris）分泌表达载体pPIC9K中,并转化入P. pastoris GS115菌株。其重组菌株GS115/pPIC9K_IL6经1% 甲醇诱导后,能分泌表达分子量约为24.5KD的重组蛋白,Western blot确证为pIL_6。该酵母表达产物无N端糖基化修饰。用依赖IL6生长的B9细胞株检测提纯后的pIL_6,其生物学活性可达8×104IU/mg。     

融合基因GAD-IL-4的克隆及其在毕赤酵母中的表达

谷氨酸脱羧酶(GAD)是糖尿病的始动靶抗原,白细胞介素4(IL-4)与自身免疫性疾病密切相关。本研究通过重叠延伸PCR(Gene splicing by overlap extension,SOE PCR)技术扩增得到融合基因GAD-IL-4,构建重组酵母表达载体pPIC9K-GAD-IL-4。线性化pPIC9K-GAD-IL-4,通过电转化法转化毕赤酵母菌GS115。以0.5%的甲醇对酵母工程菌GS115/pPIC9K-GAD-IL-4进行诱导表达。经SDS-PAGE检测,在发酵上清中出现与预期大小相符的蛋白条带,表明融合基因GAD-IL-4在酵母细胞中实现正确表达,为下一步利用重组融合蛋白GAD-IL-4奠定了良好的实验基础。     

小鼠IL-35基因毕赤酵母表达载体的构建及表达

目的构建真核酵母表达载体pPIC9K与小鼠IL-35基因的重组质粒pPIC9K-mIL-35-His,在毕赤酵母GS115菌株中诱导表达,并对其进行鉴定。方法以pET-30a-mIL-35为模板,用PCR扩增出IL-35去信号肽基因全序列,并在3'端引入His标签,构建重组质粒pPIC9K-mIL-35-His,经SalⅠ线性化重组质粒后,用电穿孔方法将该基因转染毕赤酵母细胞内。经G418梯度筛选高拷贝转化子,筛选Mut+表型后经PCR进一步鉴定IL-35基因与酵母染色体是否整合。小量诱导表达筛选出高表达菌株,大量甲醇诱导表达,以SDS-PAGE及免疫印迹(Western blot)鉴定蛋白表达。结果小鼠IL-35基因真核酵母表达载体pPIC9K-mIL-35-His构建成功,并且在GS115中通过甲醇诱导表达,经SDS-PAGE及Western blot分析,可见相对分子质量约为65 000的目的蛋白。结论实验所构建的重组质粒pPIC9K-mIL-35-His可在毕赤酵母GS115中正确的表达小鼠IL-35基因。     

金针菇免疫调节蛋白基因fip-fve在毕赤酵母GS115中诱导型和组成型表达

为获得稳定来源并且具有生物学活性的重组金针菇免疫调节蛋白(Fip-fve),将fip-fve基因转至毕赤酵母GS115中进行诱导型和组成型表达。用PCR方法从金针菇子实体基因组DNA中扩增fip-fve基因,连接至pPIC9构建诱导型表达载体pPIC9-FIP-fve,从毕赤酵母基因组DNA中扩增三磷酸甘油醛脱氢酶启动子(pgap),替换pPIC9-FIP-fve上乙醇氧化酶启动子(paox1)构建组成型表达载体pPIC9-PGAP-FIP-fve。将线性化的两种表达载体用PEG法转化毕赤酵母GS115,经组氨酸缺失培养基筛选和酵母菌落PCR鉴定后进行表达。结果表明,重组Fip-fve在以甲醇(1%,V/V)为碳源进行诱导型表达4 d达到最高,粗蛋白表达量为158.2 mg/L,在以葡萄糖(10%)和甘油(1%,V/V)为碳源进行组成型分别在表达第4天和第5天达到最高,粗蛋白分别为46.3 mg/L和29.5 mg/L。SDS-PAGE及Western blotting证明重组Fip-fve已正确表达,血细胞凝集活性检测初步证明重组Fip-fve具有良好生物学活性。     

抗菌肽CM4基因克隆及其在毕赤酵母中的表达鉴定

为了在毕赤酵母中获得抗菌肽CM4表达,将抗菌肽CM4基因克隆入表达质粒pPIC9,SacⅠ线性化的重组表达质粒pPIC9-CM4电击转化P.pastorisGS115(his-),采用MM、MD板和PCR法筛选Mut 表型,甲醇诱导表达;抗菌活性检测、Tricine-SDS-PAGE及酸性活性电泳均表明抗菌肽CM4在毕赤酵母中成功地分泌表达;重组抗菌肽CM4对黑曲霉(Aspergillus niger)、绿色木霉(Trichoderma viride)都有很强的抑菌活性。     

黑曲霉果胶裂解酶基因毕赤酵母在Pichia pastoris GS115中的表达

利用RT-PCR技术从黑曲霉(EIM-6)中扩增得到去除信号肽的果胶裂解酶基因A,将其插入到毕赤酵母表达载体pPIC9k上,构建重组表达质粒pPIC9K-pelA,电击转化毕赤酵母GS115,得到了表达成功的工程菌株。用终浓度为1.5%的甲醇对其进行诱导,将发酵上清液浓缩后,用盐酸法测定其酶活可以达到2.3U/mL。通过对重组毕赤酵母诱导表达产物进行SDS-PAGE鉴定,发现重组毕赤酵母分泌了1个约38kD的蛋白,与该酶基因产物的理论值相符,并通过水解圈法测定验证,均说明果胶裂解酶得到正确的分泌表达.     

蛇毒类凝血酶安克洛在毕赤酵母中的表达

目的:利用毕赤酵母表达具有生物学活性的蛇毒类凝血酶安克洛。方法:根据已知的天然安克洛的氨基酸序列,结合酵母偏好密码子,设计并合成了安克洛基因序列,将其克隆至表达载体pPIC9中,得到表达质粒pPIC9/Ancrod,电转至毕赤酵母GS115(His-)菌株感受态中,通过表达筛选获得工程菌株。采用5L发酵罐对工程菌进行发酵,表达安克洛。在诱导表达阶段,补加甲醇-山梨醇混合碳源。经疏水柱、肝素亲和柱和阳离子柱三步分离纯化得到重组安克洛,并鉴定其体外生物学活性。结果:重组安克洛表观相对分子质量为43000～48000,其糖基化不均匀,去糖基后蛋白肽链的相对分子质量约29000。重组安克洛被证明具有降解并凝固牛纤维蛋白原的活性,其比活力与天然安克洛相近。结论:采用毕赤酵母表达系统表达并获得有生物学活性的重组安克洛,为大规模生产打下了基础。     

重组人白细胞介素21在毕赤酵母中的分泌表达及活性分析

为了获得有活性的重组人白细胞介素21(rhIL-21),本研究建立了在毕赤酵母(Pichia pastoris)中分泌表达rhIL-21的技术。首先,通过RT-PCR从人外周血淋巴细胞中扩增IL-21cDNA,克隆到酵母表达载体pPIC9K中,构建了重组酵母表达载体pPIC9K-hIL21 cDNA;然后,线性化的载体转化毕赤酵母表达菌株GS115,经抗性梯度筛选获得了多拷贝重组酵母菌;加入甲醇诱导培养后,SDS-PAGE和Western blotting检测到培养液中有rhIL-21的分泌表达,相对分子量约为16kD,ELISA结果显示摇瓶表达量可达229.28mg/L;表达上清经阳离子交换介质SPSepharose Fast Flow纯化后,目的蛋白纯度达到95%。细胞增殖试验结果显示该rhIL-21联合刀豆蛋白A(ConA)对人淋巴细胞的增殖具有显著的促进作用。本研究首次成功在毕赤酵母表达系统中分泌表达了有生物活性的rhIL-21,为相关疾病免疫治疗的研究奠定了基础。     

植物甜蛋白des-pGlu1-Brazzein基因在乙醇氧化酶缺陷型甲醇酵母中的表达及其活性分析

采用BglⅡ酶切重组表达载体pPIC9K-Bra,纯化后电击转化甲醇酵母菌GS115,构建乙醇氧化酶缺陷型表达菌株GS115-pPIC9K-Bra,筛选鉴定后,以0.5％的甲醇进行诱导,表达的目的蛋白约占上清总蛋白的95％,纯度较高,并具有一定的甜度.成功构建了乙醇氧化酶缺陷型的甲醇酵母表达菌株,为深入研究其应用奠定了基础.     

人源抗狂犬病毒糖蛋白稳定型抗体精氨酸密码子突变株的构建及其在巴斯德毕赤酵母中的分泌表达

目的：对人源抗狂犬病毒糖蛋白（GPRV）单链二硫键稳定抗体（ScdsFv）进行精氨酸密码子修饰,实现其在酵母中的分泌表达,并检测其生物学活性。方法：参照巴斯德毕赤酵母偏好密码子,对抗GPRV ScdsFv原核表达基因进行密码子修饰,并通过点基因融合技术构建ScdsFv重组酵母表达基因,连接pPIC9K构建重组表达质粒pPIC9K-ScdsFv,电转化毕赤酵母GS115,经筛选后进行甲醇诱导表达。结果：SDS-PAGE及Western blot检测到重组表达质粒在30℃经甲醇诱导表达的蛋白相对分子质量为30000;荧光抗体试验验证ScdsFv能靶向结合GPRV;MTT试验说明ScdsFv能中和狂犬病毒,具有一定的细胞保护作用。结论：重组ScdsFv在酵母系统中可以有效表达。具有较好的生物学活性。     

用毕赤酵母表达理氏木霉的β-葡萄糖苷酶基因

目的:为提高β-葡萄糖苷酶的产量,用毕赤酵母取代理氏木霉用于生产,以弥补理氏木霉在大规模生产中的缺陷。方法:用套叠PCR法从理氏木霉基因组中扩增β-葡萄糖苷酶基因(bglⅠ)。用T4DNA连接酶和限制性DNA内酶将bglⅠ重组于P.pastoris表达载体pPIC9K的多克隆位点,获得含bglⅠ的重组表达载体pPIC9K-bglⅠ。通过电转法将其pPIC9K-bglⅠ载体转化于P.pastoris基因组,筛选高G418抗性以及高表达bglⅠ酶的重组子作为工程菌。结果:用BMGY-BMMY培养基体系,在摇瓶中发酵48 h,表达BglⅠ30 mg/L,在P.pastoris中表达的BglⅠ能水解对硝基苯-β-D-葡萄糖苷具有β-葡萄糖苷酶活性。其酶活力为56 U/L发酵液。结论:通过这种方法,可以成功地用毕赤酵母表达理氏木霉的β-葡萄糖苷酶基因。     

甘露聚糖酶基因在毕赤酵母中的表达及酶学性质研究

采用PCR的方法,以枯草芽孢杆菌Bacillus subtilis基因组 DNA 为模板,克隆出甘露聚糖酶MAN的成熟肽编码序列,将其插入巴斯德毕赤酵母Pichia pastoris表达载体pPIC9K中,并位于α-因子信号肽序列的下游,获得重组质粒pPIC9K-MAN。重组质粒线性化后用聚乙二醇法导入毕赤酵母Pichia pastoris菌株GS115中,经大量筛选,获得高效分泌表达甘露聚糖酶的毕赤酵母工程菌株MAN22。将此菌株在5 L发酵罐中进行高密度发酵,测定酶活最高达1102IU /mL,同时对重组甘露聚糖酶的性质进行了初步研究。     

在甲醇酵母Pichia pastoris胞内表达有活性的辣根过氧化物酶

为了开辟在甲醇酵母 Pichia pastoris中表达 HRP的新途径 ,将编码成熟 HRP同功酶 C基因克隆到表达载体 p PIK3.5K中 .p PIK3.5KHRP转化 GS1 1 5后 ,用 PCR筛选阳性 P.pastoris重组株 ,并用甲醇进行诱导 . Western印迹杂交分析表明目标蛋白 (约为 38k D)能被天然 HRP的多克隆抗体所识别 ,因此活性辣根过氧化物酶已在 P.pastoris胞内表达 .筛选菌株中显示了明显的过氧化物酶活性 ,同时诱导过程中血红素和 Ca Cl2 的加入对过氧化物酶的活力影响不大     

Expression and Antigenic Characterization of the Epitope-G1 of the Bovine Ephemeral Fever Virus Glycoprotein in Pichia pastoris

The epitope-G1 gene of Bovine ephemeral fever virus(BEFV) glycoprotein was synthesised by PCR and cloned into expression vector pPIC9K to construct recombinant plasmid pPIC9K-G1.Then the pPIC9K-G1 was linearized and transformed into Pichia pastoris GS115.The recombinant P.pastoris strains were selected by a G418 transformation screen and confirmed by PCR.After being induced with methanol,an expressed protein with 26 kDa molecular weight was obtained,which was much bigger than the predicted size(15.54 kDa).Deglycosylation analysis indicated the recombinant G1 was glycosylated.Western blot and ELISA tests,as well as rabbit immunization and specificity experiments indicated that the target protein had both higher reaction activity and higher immunocompetence and specificity.The recombinant G1 protein could be used as a coating antigen to develop an ELISA kit for bovine ephemeral fever diagnosis.     

Expression,purification, and characterization of recombinant human neurturin secreted from the yeast Pichia pastoris

Neurturin (NTN), a potent neurotrophic factor acting specifically on dopaminergic neurons, is comprised of 102 amino acids as a mature protein. We artificially synthesized a gene for mature human NTN (hNTN) using codons preferred by the yeast Pichia pastoris. This synthesized gene, fused in frame with sequences encoding the alpha-factor signal peptide gene from Saccharomyces cerevisiae was cloned into P. pastoris expression vector pPIC9K. The recombinant plasmid pPIC9K-alpha-hNTN was then transformed into the yeast and stable multicopy recombinant P. pastoris strains were selected by G418 resistance. SDS-PAGE and Western blot assays of culture broth from a methanol-induced expression strain demonstrated that recombinant hNTN, a 16kDa glycosylated protein, was secreted into the culture medium. The recombinant protein was purified to greater than 95% using CM-Sepharose ion exchange and Superdex 75 size-exclusion chromatography steps. Bioactivity of the recombinant hNTN was confirmed by the ability of the protein to stimulate growth of nerve fibers from the dorsal root ganglia of chick embryos in vitro.     

猪IL-18在毕赤酵母中的表达及活性分析

采用PCR方法从pGEM-IL-18重组质粒中扩增出IL-18基因并构建真核融合表达载体pPIC9K-IL-18,电激法转化入毕赤酵母GS115,采用G418抗性梯度法筛选得到多拷贝重组菌株,甲醇诱导表达,应用SDS-PAGE分析重组蛋白的表达情况,并将表达蛋白用凝胶层析柱纯化后,用MTT法检测其生物学活性。实验结果表明重组的GS115酵母菌株可表达分泌pIL-18,其表达在72h时达高峰,分泌量可达160mg/L,纯化的重组pIL-18蛋白具有显著的促进淋巴细胞增殖的活性,说明本试验已在毕赤酵母中在国内首次成功表达了具有生物学活性的pIL-18。     

Protein expression and purification of human Zbtb7A in Pichia pastoris via gene codon optimization and synthesis

Human Zbtb7A was proved to be an important molecular switch in oncogenesis. However, it is difficult to obtain its protein expression in prokaryotic system, due to high G+C content and rare codons in zbtb7a gene. Therefore, to further research the function and application of this protein, we optimized its coding sequence according to the codon bias of Pichia pastoris, synthesized the sequence with two-step PCR and confirmed the accuracy by DNA sequencing. The assembled fragment was introduced into P. pastoris expression vector pPIC9K and the resultant plasmid pPIC9K-zbtb7a-his(6) was transformed into the P. pastoris strain GS115 by electroporation. The products of the transformants induced by methanol were analyzed by 10% SDS-PAGE and identified by Western Blot assay. The expression conditions of the selected transformant were optimized. Additionally, a two-step purification protocol was applied to purify the recombinant protein. The results showed that the synthetic coding sequence of human Zbtb7A was successfully obtained and inserted into pPIC9K vector. Human Zbtb7A protein was expressed in P. pastoris and identified by western blot. The optimal conditions for its expression in P. pastoris were under a final concentration of 1% methanol and a time-course of 4d. Through the two-step purification, Zbtb7A protein was purified in high purity and its production reached up to as high as 18 mg/L. These results indicated that an effective procedure for expressing and purifying human Zbtb7A in P. pastoris was established.